NYSE$HCA

HCA Holdings Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

HCA Healthcare's financial performance for Q3 2024 was reported, marked by revenue growth and increased net income, though impacted by Hurricane Helene.

HCA Healthcare reported a strong third quarter with revenue of $17.487 billion and net income of $1.270 billion, or $4.88 per diluted share. Results were impacted by Hurricane Helene, which unfavorably impacted EPS by an estimated $0.15. The company reaffirmed its 2024 guidance, but expects results to be in the lower half of the provided ranges due to hurricane impacts.

  • Revenues totaled $17.487 billion.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share, including an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene.
  • Adjusted EBITDA totaled $3.267 billion.
  • Cash flows from operating activities totaled $3.515 billion.

Headline financials

Total Revenue

$17.5B

Previous: $16.2B+7.9%
EPS

$4.88

Previous: $3.91+24.8%
Admissions

562.1K

Previous: 536.8K+4.7%
Number of Hospitals

187

Previous: 183+2.2%
Licensed Beds at End of Period

49.9K

Previous: 49.3K+1.2%
Occupancy

71.9%

Previous: 71.4%+0.7%
Average Length of Stay (days)

4.787

Previous: 4.856-1.4%
Capital Expenditures

-$3.59B

Previous: -$3.59B-0.1%
Free Cash Flow

-$2.32B

Previous: -$2.51B+7.4%
Net Income

$1.27B

Previous: $1.08B+17.7%
Operating Income

$13.7B

Previous: $12.8B+7.1%
Gross Profit

$17.5B

Previous: $16.2B+7.9%
Cash & Equivalents

$2.89B

Previous: $891M+224.1%
Total Assets

$59.5B

Previous: $54.6B+8.9%
Stock-Based Comp

$76M

Previous: $72M+5.6%

Revenue & EPS history

HCA · Revenue · Quarterly

$17.5B

Q3 2024+7.9%vs Q3 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Forward guidance

The Company reaffirmed its 2024 estimated guidance ranges. Given the ongoing impact of the two major hurricanes on the remainder of the year, the Company estimates that results are likely to be in the lower half of the ranges provided.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.9%

Avg return

30 days after

47%

31 / 66 earnings

Positive

+16.1%

Q2 2020

Best reaction

-21.9%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.2%-8.3%-16.8%
Q4 2025+6.2%+3.4%+11.3%
Q3 2025+1.5%+6.4%+11.6%
Q2 2025+0.8%+3.1%+3.8%
Q1 2025-4.0%+1.1%+10.3%
Q4 2024-3.8%+0.7%-2.7%
Q3 2024-10.6%-9.5%-18.5%
Q2 2024+5.7%+9.0%+17.7%
Q1 2024-0.9%-1.5%+1.5%
Q4 2023+6.3%+7.9%+8.7%
Q3 2023-6.5%-6.5%+5.0%
Q2 2023-3.2%-2.9%-3.2%
Q1 2023+5.7%+2.7%+4.3%
Q4 2022-0.6%+2.6%-2.2%
Q3 2022+0.8%+4.3%+10.3%
Q2 2022+9.6%+12.9%+18.6%
Q1 2022-21.9%-21.2%-24.0%
Q4 2021-1.4%-1.1%+5.5%
Q3 2021-7.0%-5.6%-8.1%
Q2 2021+14.5%+14.2%+13.3%
Q1 2021+2.5%+0.7%+4.5%
Q4 2020+3.7%+5.9%+5.6%
Q3 2020-4.4%-9.3%+12.5%
Q2 2020+16.1%+14.6%+21.2%
Q1 2020-5.4%-2.4%-2.2%
Q4 2019+2.6%-2.0%-10.1%
Q3 2019+6.2%+5.3%+10.3%
Q2 2019-8.7%-13.0%-17.4%
Q1 2019-1.1%+0.2%-2.3%
Q4 2018+5.6%+6.1%+5.5%
Q3 2018+3.5%+4.2%+12.0%
Q2 2018+14.9%+14.7%+21.4%
Q1 2018+2.1%+1.9%+7.7%
Q4 2017+3.6%+2.1%+1.9%
Q3 2017+0.9%+0.3%+11.6%
Q2 2017-5.2%-6.6%-7.9%
Q1 2017-1.2%-0.4%-0.1%
Q4 2016+3.4%+5.7%+10.2%
Q3 2016-2.1%-4.5%-9.6%
Q2 2016-1.1%-3.8%-4.8%
Q1 2016-1.7%
Q4 2015+3.1%
Q3 2015-0.1%
Q2 2015-2.8%
Q1 2015-1.2%
Q4 2014-1.7%
Q3 2014-2.1%
Q2 2014+4.1%
Q1 2014-1.2%
Q4 2013-1.0%
Q3 2013-5.1%
Q2 2013+0.1%
Q1 2013+3.8%
Q4 2012-1.1%
Q3 2012+8.0%
Q2 2012+1.1%
Q1 2012-1.1%
Q4 2009+3.5%
Q4 2011+3.5%
Q3 2011+2.6%
Q3 2010+2.6%
Q2 2011-20.6%
Q2 2010-20.6%
Q1 2011-0.2%
Q1 2010-0.2%
Q4 2010-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro